Insulin sensitivity and glucose effectiveness measured with the minimal model in adults with GH deficiency

Endocrinology and Metabolism, Supplement

Volumn 3, Issue 2, 1996, Pages 99-104

  Fédou, Christine ^a   Brun, Jean Frédéric ^b   Raynaud, Eric ^c   Boyer, Pascal ^a   Rodiert, Michel ^a   De Boisvilliers, Fabienne ^b   Mouillon, Nathalie ^c   Orsetti, André ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b Laboratoire de Biochimie Genetique   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY COMPOSITION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL;

EID: 0029994712     PISSN: 1074939X     EISSN: 20935978     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Salomon F, Cuneo R, Sönksen PH. Insulin sensitivity and insulin resistance in growth hormone deficient adults. Horm. Res. 1993; 40: 34-36.
2. Salomon F, Cuneo R, Sönksen PH. Glucose metabolism in adults with growth hormone deficiency. Acta Paediatr. Scand. (Suppl. 377) 1991: 64-68.
3. Fédou C, Boyer P, Brun JF, Orsetti A. Tolérance au glucose et composition corporelle chez les adultes déficients en hormone de croissance (GH). (abstract) Diabetes Metab. 1994, 20:4A.
4. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Nieffing JL, Ward K, Beard JC, Palmer JP, Porte D, Jr: The contribution of insulin-dependent and insulin independent glucose to intravenous glucose tolerance in healthy human subjects. Diabetes 1994; 43: 587-592.
5. Ader MA, Pacini G, Yang YJ, Bergman RN. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes 1985; 34: 1092-1103.
6. Lukaski HC, Johnson PE, Bolonchuch WW, Lykken GE: assessment of fat free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 1985; 41: 810-817.
7. Bouix O, Brun JF, Orsetti A. The magnitiude, the kinetics and the metabolic efficiency of first-phase insulin response to intravenous glucose are related. Horm. Metab. Res. 1993; 25: 312-316.
8. Steil GM, Bergman RM. Reduced sampling for the minimal model estimate of insulin sensitivity from the modified and standard frequently sampled IVGTT. (Abstract) Diabetes (Suppl. 1) 1991; 40: 38A.
9. Brun JF, Guintrand-Hugret R, Boegner C, Bouix O, Orsetti A. Influence of short submaximal exercise on parameters of glucose assimilation analyzed with the minimal model. Metabolism 1995; 44: 833-840.
10. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1986; 38: 1512-1527.
11. Brun JF, Guintrand-Hugret R, Fons C, Carvajal J, Fédou C, Fusselier M, Bardet L, Orsetti A. Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans. Biol. Trace. Elem. Res. 1995; 47: 385-392.
12. Brun JF, Boegner C, Orsetti A. Le minimal model: un nouvel outil pour l'étude des hypoglycémies du sportif. Science & Sports 1994; 9: 47-49.
13. Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-288.
14. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
15. Johansson JO, Fowelin J, Landin K, Lager I, Bengtsson BA. Insulin resistance in adults with growth hormone deficiency. Endocrinol. Metab. (Suppl. A) 1994; 1: 80.
16. O'Neal DN, Kalfas A, Dunning PL, Christofer MJ, Sawyer SD, Ward GM, Alford FP. The effect of 3 months of recombinant human growth hormone (GH) on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. J. Clin. Endocrinol. Metab. 1995; 79: 975-983.
17. Page R, Boolell M, Kalfas A, Sawyer S, Pestell R, Ward G, Alford F. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: a minimal model analysis. Clin. Endocrinol. 1991; 35: 509-517.
18. Fowelin J, Attwall S, Lager I, Bengtsson BA. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 1993; 42: 1443-1447.
19. Beshyah SA, Henderson A, Richmond W, Johnston D. Metabolic abormalities in growth hormone-deficient adults: II. carbohydrate tolerance and lipid metabolism. Endocrinol. Metabol. 1994; 1: 173-180.
20. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 1987; 79: 790-800.
21. Welch S, Gebhart SSP, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 1990; 71: 1508-1518.
22. Brun JF, Orsetti A, Boegner C, Bringer J. Hétérogénéité des paramètres de l'assimilation glucidique mesurée par le minimal model dans les situations cliniques évocatrices d'une insulinorésistance. (Abstract) Diabetes Metab. 1994; 20: 29A.
23. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward K, Beard JC, Palmer JP, Porte DJ, Jr. Quantification of the relationship between insulin sensitivity and b-cell function in human subjects. Diabetes 1993; 42: 1163-1672.
24. Rosen T, Bosaeus I, Tollis J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin. Endocrinol. 1993; 38: 63-67.